OLUKOTUN ADEOYE Y sold 22.9% of their position (10K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $676.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/23/2025ACC: 0001242615-25-000006
Director
Since Sep 2020
-10K
Net shares
Net seller
$676.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.09K
Price / share
$66.70
Trade value
$206.10K
% of position
7.1%
12/19/2025
43.60K→40.51K
Common Stock
Direct
Shares
−6.08K
Price / share
$68.04
Trade value
$413.89K
% of position
15.0%
12/19/2025
40.51K→34.43K
Common Stock
Direct
Shares
−827.00
Price / share
$68.48
Trade value
$56.63K
% of position
2.4%
12/19/2025
34.43K→33.60K
Total
Net shares
−10K
Net value
-$676.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | S · Sale | −3.09K | $66.70 | $206.10K | 7.1% | 43.60K | 40.51K |
| Common Stock Direct | 12/19/2025 | S · Sale | −6.08K | $68.04 | $413.89K | 15.0% | 40.51K | 34.43K |
| Common Stock Direct | 12/19/2025 | S · Sale | −827.00 | $68.48 | $56.63K | 2.4% | 34.43K | 33.60K |
| Total | −10K | -$676.62K | ||||||
Derivative Transactions0
No derivative transactions reported